PT3453388T - Pharmaceutical solution comprising dopamine hydrochloride - Google Patents

Pharmaceutical solution comprising dopamine hydrochloride

Info

Publication number
PT3453388T
PT3453388T PT182018366T PT18201836T PT3453388T PT 3453388 T PT3453388 T PT 3453388T PT 182018366 T PT182018366 T PT 182018366T PT 18201836 T PT18201836 T PT 18201836T PT 3453388 T PT3453388 T PT 3453388T
Authority
PT
Portugal
Prior art keywords
pharmaceutical solution
dopamine hydrochloride
dopamine
hydrochloride
pharmaceutical
Prior art date
Application number
PT182018366T
Other languages
Portuguese (pt)
Original Assignee
Univ Du Littoral Cote Dopale
Centre Hospitalier Regional Et Univ De Lille Chru
Univ Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Du Littoral Cote Dopale, Centre Hospitalier Regional Et Univ De Lille Chru, Univ Lille filed Critical Univ Du Littoral Cote Dopale
Publication of PT3453388T publication Critical patent/PT3453388T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
PT182018366T 2015-03-09 2015-05-12 Pharmaceutical solution comprising dopamine hydrochloride PT3453388T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15305352 2015-03-09

Publications (1)

Publication Number Publication Date
PT3453388T true PT3453388T (en) 2023-05-09

Family

ID=52684176

Family Applications (1)

Application Number Title Priority Date Filing Date
PT182018366T PT3453388T (en) 2015-03-09 2015-05-12 Pharmaceutical solution comprising dopamine hydrochloride

Country Status (1)

Country Link
PT (1) PT3453388T (en)

Similar Documents

Publication Publication Date Title
IL258213A (en) Pharmaceutical compounds
GB201511790D0 (en) Pharmaceutical compound
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
GB201516411D0 (en) Pharmaceutical compound
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
IL253177A0 (en) Pharmaceutical formulation
HK1245653A1 (en) Pharmaceutical formulation
SI2774606T1 (en) Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV
IL250160A0 (en) Pharmaceutical agent
SG11201708818VA (en) Pharmaceutical compound
DK3453388T3 (en) Pharmaceutical solution comprising dopamine hydrochloride
GB201511246D0 (en) Pharmaceutical formulation
GB201517133D0 (en) New pharmaceutical use
PT3453388T (en) Pharmaceutical solution comprising dopamine hydrochloride
SG11201708817XA (en) Pharmaceutical compound
GB201517454D0 (en) New pharmaceutical use
GB201517132D0 (en) New pharmaceutical use
GB201517451D0 (en) Pharmaceutical compounds
GB201507883D0 (en) Pharmaceutical compound
GB201508611D0 (en) New pharmaceutical use